Condition
Heart Failure With Reduced Ejection Fraction clinical trials and research
As of November 12, 2026, Find a Trial lists 44 Heart Failure With Reduced Ejection Fraction clinical trials that are recruiting, at sites in 27 countries (most in United States (17), China (5), Canada (5)). By phase: Phase 4 (5), Phase 2/3 (3), Phase 3 (2), Phase 2 (2). The most active sponsors are Keimyung University Dongsan Medical Center (2), University of Virginia (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 44Clinical trials
- 27Countries
Newest Heart Failure With Reduced Ejection Fraction clinical trials
All recruiting trials (44)
-
Yoga-based cardiac rehabilitation for heart failure with reduced ejection fraction
This trial tests whether a yoga-based rehabilitation program can help people with heart failure and reduced ejection fraction compared with an educational program.
-
Lumacaftor to improve cerebral blood flow in heart failure with reduced ejection fraction
This study tests whether lumacaftor can improve brain blood flow and thinking abilities in adults with a certain type of heart failure.
-
Stepwise withdrawal of ARNI and SGLT2i in HF with normalized ejection fraction
This trial tests whether gradually stopping ARNI and SGLT2i is safe for people whose heart function has recovered after fixing a reversible heart‑disease cause.
-
Ring-style blood pressure bracelet test compared with 24-hour monitoring in people with HFrEF
A ring-type blood pressure device is being tested to see if its 24-hour readings match those from standard ambulatory monitoring in adults with heart failure and reduced ejection fraction.
-
Diet and exercise plan to help people with heart failure and preserved heart function.
This study tests whether a DASH-style, high-protein diet, resistance exercise, or both can help build muscle and improve fitness and quality of life in people with heart failure and reduced ejection fraction.
-
HFrEF polypill strategy in Sri Lanka
This study tests whether giving a heart failure polypill can reduce death from heart disease and hospitalizations in adults with HFrEF in Sri Lanka, compared with usual care.
-
How metoprolol works in HFrEF patients with low versus high beta‑blocker genetic scores
This trial will test if people with HFrEF who have a high beta‑blocker polygenic score respond differently to metoprolol than those with a low score.
-
HJB647 safety and tolerability in people with heart failure and reduced ejection fraction.
This trial will test two doses of the experimental drug HJB647 versus placebo to see if it's safe and tolerated in adults with stable heart failure and reduced or mildly reduced ejection fraction who are already on sacubitril/valsartan.
-
Digital remote care to optimize heart-failure medicines after hospital discharge
This trial will test whether a digital remote-management program helps adults recently hospitalized with HFrEF get their heart-failure medicines to recommended doses and avoid bad outcomes.
-
Digital support program for people with reduced ejection fraction heart failure
This study will test a digital support program to help adults with reduced ejection fraction heart failure manage their condition and feel more in control.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Digital stethoscope and 3-lead ECG detection of pulmonary hypertension and low ejection fraction
This project will test whether heart sounds and a three-lead ECG recorded with a digital stethoscope can find pulmonary hypertension or low left ventricular ejection fraction in adults having an echocardiogram.
-
Inspiratory muscle training combined with cardiac rehabilitation for heart failure with reduced ejection fraction
This trial will try inspiratory muscle training added to cardiac rehabilitation to see if it improves heart function and exercise responses in adults with heart failure and reduced ejection fraction.
-
Telemedicine-guided GDMT optimization for heart failure (DIGNITY)
This program will test whether telemedicine-guided care can help hospitalized patients with reduced ejection fraction get to guideline-recommended heart-failure medications and doses faster than usual care after discharge in Switzerland.
-
Remote monitoring with Caaring for people with reduced ejection fraction heart failure
Test whether using the Caaring smartphone app for remote monitoring helps people with reduced ejection fraction heart failure avoid hospital readmission over 12 weeks.
-
Evaluation of the Vsling™ Device for Heart Failure Treatment
This study is testing a new device called Vsling™ to see if it can help people with heart failure feel better by repairing their heart's function.
-
Gene therapy to improve heart function in heart failure patients
This study is testing a new gene therapy called YAP101 to see if it can help improve heart function in adults with heart failure.
-
Eccentric exercise program for older adults with heart failure and muscle loss
This study is testing a 12-week exercise program for older adults with heart failure and muscle loss to see if it can help them get stronger and feel better.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
High-fat diet for heart metabolism in non-ischemic dilated cardiomyopathy
A small human study will test whether a high-fat diet can improve heart function in adults with non-ischemic dilated cardiomyopathy and reduced ejection fraction.
-
Using omecamtiv mecarbil to treat chronic heart failure with severely reduced ejection fraction
This study is testing if a new drug called omecamtiv mecarbil can help people with severe chronic heart failure live longer and avoid serious heart problems.
-
Synchronized diaphragmatic stimulation for symptomatic heart failure
This study will test whether a small implanted device that delivers timed diaphragmatic stimulation can help people with heart failure with reduced ejection fraction (LVEF ≤40%) who remain symptomatic on guideline medical therapy.
-
Improving heart failure treatment through clinician and patient tools
This study is testing new tools for doctors and patients to see if they can help improve heart failure treatment for people with reduced heart function.
-
Observational study of heart failure patients in Vietnam
This study is looking to gather information about heart failure patients in Vietnam to see how they are doing after leaving the hospital and how different treatments affect their health over time.
-
Diet-management app and smart scale for weight loss in people with heart failure and obesity
This tests whether using a diet-management phone app at each meal plus a smart weight scale daily for 12 months helps people with heart failure and obesity live longer, avoid hospital stays, and feel less frail.
-
Impact of weight loss on heart function in obese patients with heart failure
This study is testing if losing weight with the help of a medication and a special diet can improve heart function and quality of life for obese patients with heart failure.
-
Midodrine in heart failure with reduced ejection fraction and low blood pressure
This study tests whether adding midodrine helps patients with HFrEF and hypotension when standard heart failure therapy is limited by low blood pressure.
-
Breathing-linked pacemaker pacing after bypass surgery for heart failure with reduced ejection fraction
This will test a pacemaker setting that restores the heart's natural breathing-linked rate in people with reduced ejection fraction after bypass surgery to see if it is safe and improves heart function.
-
Assessing heart function in patients with right heart failure
This study is trying to find better ways to spot and treat right heart problems in people with heart failure and high blood pressure in the lungs by looking at how their heart functions during exercise.
-
Using colchicine to treat acutely decompensated heart failure with reduced ejection fraction
This study is testing if colchicine, an anti-inflammatory medication, can help people in the hospital with heart failure feel better and improve their heart function.
-
Improving exercise capacity in heart failure patients using conduction system pacing
This study is testing if a new type of heart pacing can help people with heart failure exercise better than the standard pacing method.
-
Using empagliflozin to treat heart failure in patients with end stage renal disease
This study is testing if empagliflozin can help people with heart failure who are on dialysis feel better and improve their heart function.
-
Monitoring heart function with a wireless sensor for heart failure patients
This study tests whether a wireless sensor can help doctors keep a closer eye on heart function in patients with heart failure and mitral regurgitation to improve their treatment and outcomes.
-
SGLT2 medication and ketone effects on heart function in people with type 2 diabetes and reduced ejection fraction
This will test whether taking empagliflozin, which raises blood ketones, helps the heart pump and fill better in adults with type 2 diabetes and heart failure with reduced ejection fraction.
-
Weaning heart failure treatment for patients recovering from tachycardia-induced cardiomyopathy
This study is testing if slowly reducing heart failure medications is just as effective as keeping patients on full treatment after they’ve recovered from tachycardia-induced cardiomyopathy.
-
Using a pulmonary artery catheter and early carvedilol treatment for cardiogenic shock in heart failure patients
This study is testing if using a special heart monitor along with early treatment with carvedilol can help heart failure patients in cardiogenic shock live longer and need less medication.
-
Effects of Ferric Derisomaltose on Exercise Capacity and Quality of Life in Heart Failure Patients
This study is testing if adding Ferric Derisomaltose to regular treatment can help people with heart failure and low iron feel better and exercise more easily.
-
Effects of weight loss on heart function in obese patients with heart failure
This study tests if losing weight can help people with heart failure feel better and improve their heart function.
-
Comparing revascularization and medical treatment for heart failure with reduced ejection fraction
This study is testing if opening blocked arteries with a procedure helps people with heart failure feel better compared to just taking medication.
-
Comparing His and Left Bundle Branch Pacing for Heart Failure
This study is testing whether a new way of pacing the heart can help people with heart failure feel better and stay out of the hospital compared to the usual treatment.
-
New exercise program for older patients with heart failure
This study is testing a new exercise program for older patients with heart failure to see if it helps them feel better compared to a standard exercise program.
-
Improving heart failure treatment with advanced cardiac mapping
This study is testing if using advanced heart mapping to guide a specific heart treatment can help people with heart failure feel better compared to the usual methods.
-
Monitoring heart failure patients in real-time at Yale New Haven Health System
This study is trying to see how real-time monitoring of heart failure patients at Yale New Haven Health System can help improve their care and treatment.
-
Registry for Patients With and Without Heart Failure
This study is looking to understand different types of heart failure by gathering health information from people aged 18 and older, both with and without the condition, to improve treatment options.
Related topics
Quick answers
How many Heart Failure With Reduced Ejection Fraction clinical trials are recruiting right now?
44, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 27 countries. The most sites are in United States (17 trials), China (5 trials), Canada (5 trials), South Korea (4 trials), Italy (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 5, Phase 2/3: 3, Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.